A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
scientific article published on 27 February 2015
Author/s
author: Hagop Kantarjian, Jorge Eduardo Cortes, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Marina Konopleva, Rebecca S Garris, Naval Daver, Lianchun Xiao, Michael E Rytting, Zhihong Zeng, Mary Ann Richie, Jan A Burger
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.